Addressing this issue with co-administration of GnRH-a and hCG, the dual trigger approach, both reduced the risk of OHSS in patients with a high ovarian response (6) and contributed to the comparable or even higher pregnancy rates compared with hCG trigger (7). Here, GNRH1 is linked to ovarian hyperstimulation syndrome.